Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Inhibitor Therapeutics, Inc. | d512804d10k.htm |
| EX-23.2 - EX-23.2 - Inhibitor Therapeutics, Inc. | d512804dex232.htm |
| EX-32.2 - EX-32.2 - Inhibitor Therapeutics, Inc. | d512804dex322.htm |
| EX-32.1 - EX-32.1 - Inhibitor Therapeutics, Inc. | d512804dex321.htm |
| EX-31.1 - EX-31.1 - Inhibitor Therapeutics, Inc. | d512804dex311.htm |
| EX-31.2 - EX-31.2 - Inhibitor Therapeutics, Inc. | d512804dex312.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of Commonwealth Biotechnologies, Inc. for the year ended December 31, 2012 of our report dated May 13, 2013 included in its Registration Statement on Form S-8 (No. 333-51074) and S-3 (No. 333-51078) relating to the financial statements for the year then ended.
/s/PBMares, LLP
Richmond, Virginia
May 20, 2013